A clinical study of a tumor-selective oncolytic adenovirus (Telomelysin) in combination with ionizing radiation for head and neck and thoracic malignant tumors

Trial Profile

A clinical study of a tumor-selective oncolytic adenovirus (Telomelysin) in combination with ionizing radiation for head and neck and thoracic malignant tumors

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Telomelysin (Primary)
  • Indications Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top